Solid-State Characterization of Three Polymorphs of an Orally Available Analog of Diethylenetriaminepentaacetic Acid
- 46 Downloads
The present work investigated the physical and thermal characteristics of three polymorphic forms (namely, PF1, PF2, and PF3) of a diethyl ester analog of diethylenetriaminepentaacetic acid (C2E2) produced under varying conditions. The identity of each form of C2E2 was confirmed by 1H-NMR, 13C-NMR, and mass spectroscopy. The different polymorphic forms exhibited solubilities ranging from 40 to 150 mg/mL. Powder X-ray diffraction (PXRD) and electron microscopy confirmed that all three forms were crystalline, two of which being scaly, and the third being well-formed. Infrared and Raman spectroscopy revealed differences in the C = O bonding region while differential scanning calorimetry (DSC) and thermal gravimetric analysis (TGA) showed widely different melting points with only one thermal event for each compound. The comparison of the melting points and heats of fusion show that the PF1 is monotropically related to both PF2 and PF3, while PF2 and PF3 are enantropically related. Our finding indicates that PF3 is the thermodynamically stable polymorph and will be used for in vitro and in vivo experiments.
KEY WORDSchelator polymorphs physical characterization thermal characterization physical-chemical properties
- 1.National Council on Radiation Protection. Development of a biokinetics model for radionuclide-contaminated wounds and procedures for their assessment, dosimetry and treatment. NCRP Report No 156. 2007.Google Scholar
- 2.Pentetate calcium trisodium [package insert]. Gloucester, U.K.: Hameln; 2013.Google Scholar
- 3.Aulton M. Aulton’s pharmaceutics: the design and manufacture of medicines 3rd ed. London: Churchill Livingstone Elsevier; 2008. p. 441–82.Google Scholar
- 7.Particle Sciences Technical Brief 2011 Volume 9, Biopharmaceutical Classification System and Formulation Development. Available at: http://www.particlesciences.com/docs/technical_briefs/TB_2011_9.pdf. Accessed Nov 2017.
- 8.Sachin L, Grant DJW. Thermodanymics in polymorphs. In: Hilfiker R, editor. Polymorphism in the Pharmaceutical Industry. Weinheim: WILEY-VCH Verlag GmbH & Co; 2006. p. 21–42.Google Scholar
- 14.Smith BT. Remington education: physical pharmacy. London: Pharmaceutical Press; 2016. p. 31–50.Google Scholar
- 19.Lee EH. A practical guide to pharmaceutical polymorph screening & selection. AJPS. 2014;9(4):163–75.Google Scholar